This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published on July 11
Healthcare billing practices are under intense scrutiny from regulators, creating a perfect environment for companies with strong compliance solutions and clean records to thrive.
Healthcare organizations are now prioritizing compliance software as a must-have expense, not a luxury. This means steady, growing demand for the tech companies in this group.
As patients and employers lose confidence in insurers under investigation, competitors with strong reputations stand to gain millions of new members and billions in revenue.
The DOJ investigation into UnitedHealth's Medicare billing practices signals a broader regulatory crackdown across healthcare. This creates opportunity for compliance software providers and competing insurers with strong records. Companies in this group are positioned to benefit from increased compliance spending and potential market share shifts.
This collection includes two types of companies: health-tech firms providing compliance software and auditing tools, and rival insurers with strong compliance records. This represents a tactical, event-driven portfolio aimed at capturing a specific opportunity within the healthcare sector following increased scrutiny.
These companies were specifically selected to capture the dual opportunities created by the DOJ probe: the increased demand for compliance technology and the potential for market share shifts among insurance providers. Each company offers exposure to either the technology enabling compliance or the possibility of gaining customers from competitors under scrutiny.
Summarised market capitalisation data for the 'Healthcare Billing Integrity' stock basket, including breakdown of constituents.
CI: $82.08B
HUM: $35.50B
ELV: $77.73B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
+5
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
BHP Group recently posted a massive earnings beat driven by record copper profitability, allowing the miner to raise its dividend to a four-year high. This performance highlights a structural shift toward electrification metals, creating opportunities for industrial equipment suppliers and competing copper producers.
Here are a few of the assets in this group. Create an account to unlock the full list.
Cigna Corp
CI
Current Price
$279.68
As a primary competitor to UnitedHealth, Cigna could attract new members from employer groups and individuals seeking a more trusted health insurance ...
As a primary competitor to UnitedHealth, Cigna could attract new members from employer groups and individuals seeking a more trusted health insurance provider amid the ongoing investigation.
Humana
HUM
Current Price
$375.33
Humana, a major player in the Medicare Advantage market, is well-positioned to gain market share from UnitedHealth as seniors and other beneficiaries ...
Humana, a major player in the Medicare Advantage market, is well-positioned to gain market share from UnitedHealth as seniors and other beneficiaries may switch to insurers with a stronger reputation for compliance.
ELEVANCE HEALTH INC
ELV
Current Price
$401.32
Elevance Health competes directly with UnitedHealth and could benefit from a flight to quality, capturing market share as customers and partners reass...
Elevance Health competes directly with UnitedHealth and could benefit from a flight to quality, capturing market share as customers and partners reassess their relationships with the embattled insurer.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+97.29%
On average, analysts expect assets in this group to grow 97.29% over the next year.
11 of 14 assets in this group are rated Buy by professional analysts.
